TVGN · NASDAQ · Biotechnology

Tevogen Bio (TVGN)

Develops ExacTcell-based T-cell therapy candidates for COVID-19, cancer and Long COVID.

$6.92
Pre-market−0.25 (−3.49%)
At close$7.17(0.00%)

Breakdown13F · 13D/G · Form 4

Institutions29 holders · as of Mar 31, 20263.26%135.8K shares
Insiders9 holders · as of Jul 14, 2026103.80%4.32M shares
Adds to107.06%

4.16M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing

Two share counts disagree (6.51M in the company's Sep 3, 2026 report, 4.16M elsewhere); stakes use the report.

A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.

These groups come from separate filings that can overlap, so they add to 107.06%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Ryan H. SaadiInsiderdirector, 10 percent owner, officer: Chief Executive Officer
89.08%3.71M13Dfiled Jul 14, 2026
Kirti DesaiInsiderofficer: Chief Financial Officer
5.84%242,983Form 4filed Jul 10, 2026
Neal FlomenbergInsiderofficer: See Remarks
1.85%76,940Form 4filed Mar 17, 2026
Curtis L. PattonInsiderdirector
1.54%64,192Form 4filed Jul 10, 2026
Jeffrey L. FeikeInsiderdirector
1.36%56,435Form 4filed Jul 10, 2026
Victor J. SordilloInsiderdirector
1.24%51,539Form 4filed Jul 10, 2026
Keow Lin GohInsiderdirector
1.17%48,678Form 4filed Jul 10, 2026
Susan M. PodlogarInsiderdirector
1.17%48,678Form 4filed Jul 10, 2026
Vanguard Capital Management LLCInstitution
0.80%33,24813Fas of Mar 31, 2026
BlackRock, Inc.Institution
0.59%24,39513Fas of Mar 31, 2026
Sadiq KhanInsiderofficer: Chief Commercial Officer
0.56%23,392Form 4filed Jul 1, 2025
Morgan StanleyInstitution
0.42%17,33413Fas of Mar 31, 2026
Geode Capital Management, LLCInstitution
0.38%15,73413Fas of Mar 31, 2026
Deutsche Bank AG\Institution
0.37%15,32413Fas of Mar 31, 2026
FMR LLCInstitution
0.24%10,15713Fas of Mar 31, 2026
Russell Investments Group, Ltd.Institution
0.14%5,80613Fas of Mar 31, 2026
Vanguard Portfolio Management LLCInstitution
0.11%4,52513Fas of Mar 31, 2026
UBS Group AGInstitution
0.09%3,56713Fas of Mar 31, 2026
Vanguard Fiduciary Trust CoInstitution
0.03%1,36813Fas of Mar 31, 2026
Rhumbline AdvisersInstitution
0.02%1,00313Fas of Mar 31, 2026
Tower Research Capital LLC (TRC)Institution
0.02%94113Fas of Mar 31, 2026
JPMorgan Chase & CoInstitution
0.01%47913Fas of Mar 31, 2026
Mirae Asset Global Etfs Holdings Ltd.Institution
0.01%37313Fas of Mar 31, 2026
Wells Fargo & Company/MNInstitution
0.01%31113Fas of Mar 31, 2026
BNP Paribas Arbitrage, SNCInstitution
0.01%28213Fas of Mar 31, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

29 holders · 135.8K shares

HolderShares% outstandingChg q/qFiled
Vanguard Capital Management LLC33.2K0.80%May 15, 2026
BlackRock, Inc.24.4K0.59%May 13, 2026
Morgan Stanley17.3K0.42%May 15, 2026
Geode Capital Management, LLC15.7K0.38%May 15, 2026
Deutsche Bank AG\15.3K0.37%May 6, 2026
FMR LLC10.2K0.24%May 15, 2026
Russell Investments Group, Ltd.5.8K0.14%May 8, 2026
Vanguard Portfolio Management LLC4.5K0.11%May 8, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Ryan H. Saadi62.00%13DDec 16, 2025
Saadi Ryan H.59.70%3.71M13DJul 14, 2026

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Mar 13, 2026
Neal Flomenbergofficer: See Remarks
Sale501$6.4076,940
Mar 11, 2026
Neal Flomenbergofficer: See Remarks
Sale452$7.2677,441
Mar 10, 2026
Neal Flomenbergofficer: See Remarks
Sale19$7.7577,893

CongressHouse and Senate disclosures

Not reported.